Specifically, it has been suggested that resistin can inhibit dopamine and noradrenaline release in the hypothalamus and can decrease intrasynaptic monoamine levels, which in turn could lead to the predisposition of the development of depression symptoms [12]. The gene discussed is RETN; the disease is depressive symptom measurement.